Teicoplanin: an alternative drug for the treatment of COVID-19?

In December 2019, a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged from China causing pneumonia outbreaks, first in the Wuhan region of China and then spread worldwide because of its probable high transmission efficiency. Owing to the lack of efficient...

Descripción completa

Detalles Bibliográficos
Autores principales: Baron, Sophie Alexandra, Devaux, Christian, Colson, Philippe, Raoult, Didier, Rolain, Jean-Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102624/
https://www.ncbi.nlm.nih.gov/pubmed/32179150
http://dx.doi.org/10.1016/j.ijantimicag.2020.105944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102624/
https://www.ncbi.nlm.nih.gov/pubmed/32179150
http://dx.doi.org/10.1016/j.ijantimicag.2020.105944

Ejemplares similares